HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment vs DSP Healthcare Fund - Direct - Growth
NAV, returns and costs — not a recommendation.
 HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment |  DSP Healthcare Fund - Direct - Growth | |
|---|---|---|
| NAV | ₹22.3 | ₹51.166 |
| NAV date | 2026-08-18 | 2026-08-19 |
| 1 year | +25.46% | +15.67% |
| 3 year (p.a.) | +32.38% | +22.20% |
| 5 year (p.a.) | +32.38% | +16.49% |
| Expense ratio | 0.92% | 0.51% |
| Fund size | ₹2362.44 Cr | ₹3,309.17 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.